Oppenheimer analyst Noah Kaye lowered the firm’s price target on Itron (ITRI) to $145 from $155 and keeps an Outperform rating on the shares. The firm notes shares traded down sharply Thursday after Itron beat Q3 consensus estimates, while guiding the Q4 sales and bookings outlook lower than the Street estimate. As investors digest an incrementally slower hardware sales cycle related to utility regulatory/planning uncertainty, along with lapping $1/share discrete tax benefits into FY26, Oppenheimer anticipates investor caution until signals of increased project flow rates present.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ITRI:
